Literature DB >> 19683621

Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.

Uta Flucke, Pieter J Slootweg, Thomas Mentzel, Patrick Pauwels, Theo J M Hulsebos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19683621     DOI: 10.1016/j.humpath.2009.04.018

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  6 in total

Review 1.  [Epithelioid sarcoma: morphologic variants and differential diagnosis].

Authors:  T Mentzel
Journal:  Pathologe       Date:  2010-03       Impact factor: 1.011

Review 2.  Molecular classification of soft tissue sarcomas and its clinical applications.

Authors:  Shilpa Jain; Ruliang Xu; Victor G Prieto; Peng Lee
Journal:  Int J Clin Exp Pathol       Date:  2010-04-23

3.  Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.

Authors:  Francois Le Loarer; Lei Zhang; Christopher D Fletcher; Agnes Ribeiro; Samuel Singer; Antoine Italiano; Agnes Neuville; Aurélie Houlier; Frederic Chibon; Jean-Michel Coindre; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2014-03-03       Impact factor: 5.006

4.  Extremely rare case of vulvar myxoid epithelioid sarcoma.

Authors:  Joana Lima Rego; Georgia Fontes Cintra; Ana Karina Junqueira Netto; Lucas Faria Abrahão-Machado; Audrey Tsunoda
Journal:  Case Rep Obstet Gynecol       Date:  2015-02-08

Review 5.  Oncogenic roles of SMARCB1/INI1 and its deficient tumors.

Authors:  Kenichi Kohashi; Yoshinao Oda
Journal:  Cancer Sci       Date:  2017-04-12       Impact factor: 6.716

6.  Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions.

Authors:  Lisa M Sullivan; Andrew L Folpe; Bruce R Pawel; Alexander R Judkins; Jaclyn A Biegel
Journal:  Mod Pathol       Date:  2012-10-12       Impact factor: 7.842

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.